Drug information for NEVIRAPINE
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
SUSPENSION; ORAL
50MG/5ML
Tentative Approval
NEVIRAPINE
Nevirapine
AUROBINDO PHARMA LTD
77702
2006-01-06 Letter
TABLET, FOR SUSPENSION; ORAL
100MG
Tentative Approval
NEVIRAPINE
Nevirapine
CIPLA LIMITED
202212
2012-05-03 Letter
TABLET, FOR SUSPENSION; ORAL
50MG
Tentative Approval
NEVIRAPINE
Nevirapine
CIPLA LIMITED
"
TABLET; ORAL
200MG
Tentative Approval
NEVIRAPINE
Nevirapine
MYLAN PHARMS INC
202523
TABLET; ORAL
200MG
Tentative Approval
NEVIRAPINE
Nevirapine
SCIEGEN PHARM INC.
203176
2012-05-03 Letter
TABLET; ORAL
200MG
Tentative Approval
NEVIRAPINE
Nevirapine
RANBAXY
77429
2005-06-21 Letter
TABLET; ORAL
200MG
Tentative Approval
NEVIRAPINE
Nevirapine
AUROBINDO
77521
2005-06-21 Letter
TABLET; ORAL
200MG
Tentative Approval
NEVIRAPINE
Nevirapine
CIPLA LIMITED
77956
2006-05-21 Letter
TABLET; ORAL
200MG
Tentative Approval
NEVIRAPINE
Nevirapine
STRIDES ACROLAB
78195
2006-08-18 Letter
TABLET; ORAL
200MG
Tentative Approval
NEVIRAPINE
Nevirapine
HETERO DRUGS
78584
2007-08-14 Letter
TABLET; ORAL
200MG
Tentative Approval
NEVIRAPINE
Nevirapine
HUAHAI US INC.
78644
2007-07-16 Letter
TABLET; ORAL
200MG
Tentative Approval
NEVIRAPINE
Nevirapine
MATRIX LABS
78864
2008-05-21 Letter
TABLET; ORAL
200MG
Tentative Approval
NEVIRAPINE
Nevirapine
EMCURE PHARMA
78887
2007-10-04 Letter
TABLET; ORAL
200MG
Tentative Approval
NEVIRAPINE
Nevirapine
MACLEODS PHARMA
90688
2009-04-03 Letter
Drug Adverse Effects information for NEVIRAPINE
Role code
Indications
Reaction
# Reports
PS
ACQUIRED IMMUNODEFICIENCY SYNDROME
ABORTION SPONTANEOUS
1
PS
ACQUIRED IMMUNODEFICIENCY SYNDROME
MATERNAL DRUGS AFFECTING FOETUS
1
PS
BASEDOW'S DISEASE
DRUG INTERACTION
2
PS
BASEDOW'S DISEASE
HYPOTHYROIDISM
2
PS
DRUG LEVEL
DEHYDRATION
1
PS
DRUG LEVEL
DIARRHOEA
1
PS
HIV INFECTION
ABSCESS NECK
3
PS
HIV INFECTION
ANAEMIA
4
PS
HIV INFECTION
ASCITES
4
PS
HIV INFECTION
CHOLESTASIS
3
PS
HIV INFECTION
CHRONIC HEPATITIS
4
PS
HIV INFECTION
CREATININE RENAL CLEARANCE DECREASED
8
PS
HIV INFECTION
DEHYDRATION
2
PS
HIV INFECTION
DIARRHOEA
2
PS
HIV INFECTION
DRUG INTERACTION
12
PS
HIV INFECTION
HEPATIC ENZYME INCREASED
4
PS
HIV INFECTION
HEPATITIS ACUTE
3
PS
HIV INFECTION
HYPOTHYROIDISM
12
PS
HIV INFECTION
IMMUNE RECONSTITUTION SYNDROME
3
PS
HIV INFECTION
JAUNDICE
3
PS
HIV INFECTION
KLEBSIELLA INFECTION
3
PS
HIV INFECTION
LARGE INTESTINAL HAEMORRHAGE
4
PS
HIV INFECTION
LYMPHADENITIS BACTERIAL
3
PS
HIV INFECTION
MALARIA
2
PS
HIV INFECTION
MATERNAL EXPOSURE DURING PREGNANCY
4
PS
HIV INFECTION
MELAENA
4
PS
HIV INFECTION
MENINGITIS CRYPTOCOCCAL
1
PS
HIV INFECTION
PORTAL HYPERTENSION
4
PS
HIV INFECTION
PREGNANCY
4
PS
HIV INFECTION
TUBERCULOSIS
2
PS
HIV INFECTION
VARICES OESOPHAGEAL
4
PS
HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION
MENINGITIS CRYPTOCOCCAL
1
PS
MATERNAL EXPOSURE DURING PREGNANCY
FOETAL DISTRESS SYNDROME
3
PS
PROPHYLAXIS
MENINGITIS CRYPTOCOCCAL
1
PS
THYROID CYST
DRUG INTERACTION
2
PS
THYROID CYST
HYPOTHYROIDISM
2
SS
ACQUIRED IMMUNODEFICIENCY SYNDROME
CARDIAC VENTRICULAR DISORDER
2
SS
ACQUIRED IMMUNODEFICIENCY SYNDROME
MATERNAL DRUGS AFFECTING FOETUS
4
SS
ACQUIRED IMMUNODEFICIENCY SYNDROME
VENTRICULAR SEPTAL DEFECT
4
SS
ADJUSTMENT DISORDER
SUICIDE ATTEMPT
2
SS
ANTIRETROVIRAL THERAPY
CACHEXIA
8
SS
ANTIRETROVIRAL THERAPY
CHRONIC FATIGUE SYNDROME
8
SS
ANTIRETROVIRAL THERAPY
COUGH
3
SS
ANTIRETROVIRAL THERAPY
DEPRESSION
8
SS
ANTIRETROVIRAL THERAPY
DEVELOPMENTAL DELAY
3
SS
ANTIRETROVIRAL THERAPY
DYSPNOEA
3
SS
ANTIRETROVIRAL THERAPY
FACIAL WASTING
8
SS
ANTIRETROVIRAL THERAPY
FOETAL EXPOSURE DURING PREGNANCY
6
SS
ANTIRETROVIRAL THERAPY
GLUCOSE TOLERANCE IMPAIRED
6
SS
ANTIRETROVIRAL THERAPY
HEPATOMEGALY
3
SS
ANTIRETROVIRAL THERAPY
HEPATOSPLENOMEGALY
3
SS
ANTIRETROVIRAL THERAPY
HIGH DENSITY LIPOPROTEIN DECREASED
6
SS
ANTIRETROVIRAL THERAPY
HYPERTRIGLYCERIDAEMIA
6
SS
ANTIRETROVIRAL THERAPY
HYPOAESTHESIA
8
SS
ANTIRETROVIRAL THERAPY
LACTIC ACIDOSIS
6
SS
ANTIRETROVIRAL THERAPY
LIPOATROPHY
6
SS
ANTIRETROVIRAL THERAPY
LIPODYSTROPHY ACQUIRED
8
SS
ANTIRETROVIRAL THERAPY
LYMPHADENITIS
3
SS
ANTIRETROVIRAL THERAPY
LYMPHADENOPATHY
3
SS
ANTIRETROVIRAL THERAPY
MUSCLE SPASTICITY
3
SS
ANTIRETROVIRAL THERAPY
PYREXIA
3
SS
ANTIRETROVIRAL THERAPY
RENAL FAILURE ACUTE
3
SS
ANTIRETROVIRAL THERAPY
VASODILATATION
8
SS
ANTIVIRAL TREATMENT
ABORTION SPONTANEOUS
2
SS
ANTIVIRAL TREATMENT
MATERNAL EXPOSURE DURING PREGNANCY
2
SS
BACK PAIN
SUICIDAL IDEATION
2
SS
BACK PAIN
SUICIDE ATTEMPT
3
SS
DYSPEPSIA
SUICIDAL IDEATION
2
SS
DYSPEPSIA
SUICIDE ATTEMPT
3
SS
HEAD DISCOMFORT
SUICIDAL IDEATION
2
SS
HEAD DISCOMFORT
SUICIDE ATTEMPT
3
SS
HIV INFECTION
ABSCESS NECK
3
SS
HIV INFECTION
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS
10
SS
HIV INFECTION
ANAEMIA
3
SS
HIV INFECTION
ANAPHYLACTIC SHOCK
10
SS
HIV INFECTION
ASTHENIA
10
SS
HIV INFECTION
BLOOD THYROID STIMULATING HORMONE INCREASED
2
SS
HIV INFECTION
CASTLEMAN'S DISEASE
10
SS
HIV INFECTION
CD4 LYMPHOCYTES INCREASED
17
SS
HIV INFECTION
CEREBRAL TOXOPLASMOSIS
17
SS
HIV INFECTION
CREATININE RENAL CLEARANCE DECREASED
8
SS
HIV INFECTION
DIABETES MELLITUS
2
SS
HIV INFECTION
DIARRHOEA
17
SS
HIV INFECTION
DRUG INTERACTION
2
SS
HIV INFECTION
DRUG RESISTANCE
27
SS
HIV INFECTION
EAR INFECTION
17
SS
HIV INFECTION
EPILEPSY
17
SS
HIV INFECTION
FOETAL EXPOSURE DURING PREGNANCY
6
SS
HIV INFECTION
GASTROINTESTINAL DISORDER
17
SS
HIV INFECTION
GENERALISED ERYTHEMA
10
SS
HIV INFECTION
HEPATOTOXICITY
17
SS
HIV INFECTION
HERPES SIMPLEX
3
SS
HIV INFECTION
IMMUNE RECONSTITUTION SYNDROME
23
SS
HIV INFECTION
KLEBSIELLA INFECTION
3
SS
HIV INFECTION
LIPOATROPHY
3
SS
HIV INFECTION
LYMPHADENITIS BACTERIAL
3
SS
HIV INFECTION
MALARIA
2
SS
HIV INFECTION
MATERNAL EXPOSURE DURING PREGNANCY
4
SS
HIV INFECTION
MENINGITIS
17
SS
HIV INFECTION
MENINGITIS CRYPTOCOCCAL
2
SS
HIV INFECTION
MONOPLEGIA
17
SS
HIV INFECTION
MUSCLE ATROPHY
3
SS
HIV INFECTION
NAUSEA
17
SS
HIV INFECTION
OESOPHAGEAL CANDIDIASIS
17
SS
HIV INFECTION
PANCYTOPENIA
10
SS
HIV INFECTION
PNEUMONIA STREPTOCOCCAL
17
SS
HIV INFECTION
POLYNEUROPATHY
17
SS
HIV INFECTION
PORTAL HYPERTENSION
44
SS
HIV INFECTION
PREMATURE BABY
8
SS
HIV INFECTION
QUADRIPARESIS
17
SS
HIV INFECTION
SCROTAL ULCER
3
SS
HIV INFECTION
SEPSIS
17
SS
HIV INFECTION
SUICIDAL IDEATION
4
SS
HIV INFECTION
SUICIDE ATTEMPT
6
SS
HIV INFECTION
TREATMENT FAILURE
17
SS
HIV INFECTION
TREATMENT NONCOMPLIANCE
17
SS
HIV INFECTION
TUBERCULOSIS
2
SS
HIV INFECTION
VENTRICULAR SEPTAL DEFECT
10
SS
HIV INFECTION
VIITH NERVE PARALYSIS
17
SS
HIV INFECTION
VIRAL LOAD INCREASED
17
SS
HIV INFECTION
VOMITING
17
SS
HIV INFECTION
WEIGHT DECREASED
10
SS
HIV INFECTION
WEIGHT INCREASED
3
SS
HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION
MENINGITIS CRYPTOCOCCAL
2
SS
MATERNAL EXPOSURE DURING PREGNANCY
MATERNAL EXPOSURE DURING PREGNANCY
8
SS
MATERNAL EXPOSURE DURING PREGNANCY
PREMATURE BABY
4
SS
MATERNAL EXPOSURE DURING PREGNANCY
VENTRICULAR SEPTAL DEFECT
8
SS
MATERNAL EXPOSURE TIMING UNSPECIFIED
FOETAL EXPOSURE DURING PREGNANCY
8
SS
MATERNAL EXPOSURE TIMING UNSPECIFIED
PREMATURE BABY
8
SS
MATERNAL EXPOSURE TIMING UNSPECIFIED
VENTRICULAR SEPTAL DEFECT
8
SS
PARAESTHESIA
SUICIDAL IDEATION
2
SS
PARAESTHESIA
SUICIDE ATTEMPT
3
SS
PNEUMONIA STREPTOCOCCAL
CD4 LYMPHOCYTES INCREASED
1
SS
PNEUMONIA STREPTOCOCCAL
CEREBRAL TOXOPLASMOSIS
1
SS
PNEUMONIA STREPTOCOCCAL
DIARRHOEA
1
SS
PNEUMONIA STREPTOCOCCAL
DRUG RESISTANCE
1
SS
PNEUMONIA STREPTOCOCCAL
EAR INFECTION
1
SS
PNEUMONIA STREPTOCOCCAL
EPILEPSY
1
SS
PNEUMONIA STREPTOCOCCAL
GASTROINTESTINAL DISORDER
1
SS
PNEUMONIA STREPTOCOCCAL
HEPATOTOXICITY
1
SS
PNEUMONIA STREPTOCOCCAL
IMMUNE RECONSTITUTION SYNDROME
1
SS
PNEUMONIA STREPTOCOCCAL
MENINGITIS
1
SS
PNEUMONIA STREPTOCOCCAL
MONOPLEGIA
1
SS
PNEUMONIA STREPTOCOCCAL
NAUSEA
1
SS
PNEUMONIA STREPTOCOCCAL
OESOPHAGEAL CANDIDIASIS
1
SS
PNEUMONIA STREPTOCOCCAL
PNEUMONIA STREPTOCOCCAL
1
SS
PNEUMONIA STREPTOCOCCAL
POLYNEUROPATHY
1
SS
PNEUMONIA STREPTOCOCCAL
QUADRIPARESIS
1
SS
PNEUMONIA STREPTOCOCCAL
SEPSIS
1
SS
PNEUMONIA STREPTOCOCCAL
TREATMENT FAILURE
1
SS
PNEUMONIA STREPTOCOCCAL
TREATMENT NONCOMPLIANCE
1
SS
PNEUMONIA STREPTOCOCCAL
VIITH NERVE PARALYSIS
1
SS
PNEUMONIA STREPTOCOCCAL
VIRAL LOAD INCREASED
1
SS
PNEUMONIA STREPTOCOCCAL
VOMITING
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
COUGH
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
DYSPNOEA
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
FOETAL EXPOSURE DURING PREGNANCY
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
HEPATOMEGALY
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
LACTIC ACIDOSIS
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
PYREXIA
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
RENAL FAILURE ACUTE
1
SS
PRODUCTIVE COUGH
SUICIDAL IDEATION
6
SS
PRODUCTIVE COUGH
SUICIDE ATTEMPT
9
SS
PROPHYLAXIS
DEVELOPMENTAL DELAY
1
SS
PROPHYLAXIS
FOETAL EXPOSURE DURING PREGNANCY
1
SS
PROPHYLAXIS
HEPATOSPLENOMEGALY
1
SS
PROPHYLAXIS
LACTIC ACIDOSIS
1
SS
PROPHYLAXIS
LYMPHADENITIS
1
SS
PROPHYLAXIS
LYMPHADENOPATHY
1
SS
PROPHYLAXIS
MENINGITIS CRYPTOCOCCAL
2
SS
PROPHYLAXIS
MUSCLE SPASTICITY
1
SS
PROPHYLAXIS AGAINST HIV INFECTION
DIABETES MELLITUS
2
SS
ROUTINE HEALTH MAINTENANCE
SUICIDAL IDEATION
2
SS
ROUTINE HEALTH MAINTENANCE
SUICIDE ATTEMPT
3
SS
SUPPLEMENTATION THERAPY
FOETAL EXPOSURE DURING PREGNANCY
1
SS
SUPPLEMENTATION THERAPY
PREMATURE BABY
1
SS
SUPPLEMENTATION THERAPY
VENTRICULAR SEPTAL DEFECT
1
SS
THYROID CYST
BLOOD THYROID STIMULATING HORMONE INCREASED
1
SS
THYROID CYST
DRUG INTERACTION
1
C
ASYMPTOMATIC HIV INFECTION
AGITATION
3
C
ASYMPTOMATIC HIV INFECTION
CONFUSIONAL STATE
3
C
ASYMPTOMATIC HIV INFECTION
MALAISE
3
C
BASEDOW'S DISEASE
DRUG INTERACTION
1
C
BLOOD TRIGLYCERIDES INCREASED
ABNORMAL SENSATION IN EYE
1
C
BLOOD TRIGLYCERIDES INCREASED
EYELID OEDEMA
1
C
BLOOD TRIGLYCERIDES INCREASED
LOCAL SWELLING
1
C
BLOOD TRIGLYCERIDES INCREASED
SWELLING FACE
1
C
HIV INFECTION
ANGIOEDEMA
3
C
HIV INFECTION
CLOSTRIDIUM DIFFICILE COLITIS
2
C
HIV INFECTION
DRUG INTERACTION
6
C
HIV INFECTION
DYSPHAGIA
3
C
HIV INFECTION
DYSPNOEA
3
C
HIV INFECTION
ENCEPHALOPATHY
2
C
HIV INFECTION
LUNG DISORDER
2
C
HIV INFECTION
MATERNAL DRUGS AFFECTING FOETUS
3
C
HIV INFECTION
RENAL FAILURE ACUTE
2
C
HIV INFECTION
RESPIRATORY DISTRESS
12
C
HIV INFECTION
SHOCK
2
C
HIV INFECTION
SUPERINFECTION
2
C
HIV INFECTION
VENTRICULAR SEPTAL DEFECT
9
C
PRODUCT USED FOR UNKNOWN INDICATION
ANGIOEDEMA
6
C
PRODUCT USED FOR UNKNOWN INDICATION
DYSPHAGIA
6
C
PRODUCT USED FOR UNKNOWN INDICATION
DYSPNOEA
6
C
THYROID CYST
DRUG INTERACTION
1
C
URINARY TRACT INFECTION
GRAND MAL CONVULSION
1
I
DYSMENORRHOEA
ANAEMIA
4
I
DYSMENORRHOEA
MENORRHAGIA
4
I
HIV INFECTION
ANAEMIA
2
I
HIV INFECTION
MENORRHAGIA
2
I
MENORRHAGIA
ANAEMIA
4
I
MENORRHAGIA
MENORRHAGIA
4
Ads by Google